(Reuters) - Honeywell International is considering selling its personal protective equipment (PPE) division in a deal that could value the unit at more than $2 billion, Bloomberg News reported on ...

“This is an exciting finding, that a cheap over-the-counter antibiotic ointment can stimulate the human body to activate an antiviral response,” said Akiko Iwasaki, a professor of ...

Honeywell International ... showing a 1.56% escalation compared to the year-ago quarter. HON's full-year Zacks Consensus Estimates are calling for earnings of $9.94 per share and revenue of ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

A Scottsdale, Arizona-based smart-home automation company has agreed to acquire Snap One Holdings Corp. in a deal valued at $1.4 billion ... for $10.75 per share in cash. Snap One makes smart ...

Honeywell will pay private equity firm New Mountain Capital $1.3 billion for life sciences software group Sparta Systems. Honeywell International (HON) agreed Monday to buy privately-held ...

This literature review discusses various topical antibiotic treatment options for ... compared with oral or parenteral antimicrobials. [1] In the USA, a variety of topical agents are available ...

Note: All Broadway Box Office data is presented for informational purposes only. BroadwayWorld makes no guarantees as to the accuracy of the data, or the matter in which it's presented.

For a security, the Price/Earnings Ratio is given by dividing the Last Sale Price by the Actual EPS (Earnings Per Share). Nasdaq Dividend History provides straightforward stock’s historical ...

It earned another $1.3 million overseas from 27 markets, for a global total of $22.8 million. Universal is releasing the movie via its deal with Jordan Peele’s Monkey Paw Productions.

GR was a paid consultant to Cubist Pharmaceuticals on a previous project on "Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant pseudomonas aeruginosa ...